Open Access
Med Sci (Paris)
Volume 36, Number 8-9, Août–Septembre 2020
Page(s) 689 - 691
Section Le Magazine
Published online 21 August 2020
  1. Nagao-Kitamoto H, Shreiner AB, Gillilland MG, III, et al. Functional characterization of inflammatory bowel disease–associated gut dysbiosis in gnotobiotic mice. Cell Mol Gastroenterol Hepatol 2016 ; 2 : 468–481. [Google Scholar]
  2. Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010 ; 328 : 228–231. [Google Scholar]
  3. Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol 2015 ; 33 : 496–503. [CrossRef] [PubMed] [Google Scholar]
  4. Chassaing B, Koren O, Carvalho FA, et al. AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition. Gut 2014 ; 63 : 1069–1080. [CrossRef] [PubMed] [Google Scholar]
  5. Carvalho FA, Koren O, Goodrich JK, et al. Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host Microbe 2012 ; 12 : 139–152. [CrossRef] [PubMed] [Google Scholar]
  6. Chassaing B, Darfeuille-Michaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011 ; 140 : 1720–8 e3. [Google Scholar]
  7. Chassaing B, Ley RE, Gewirtz AT. Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice. Gastroenterology 2014 ; 147 : 1363–77 e17. [Google Scholar]
  8. Sevrin G, Massier S, Chassaing B, et al. Adaptation of adherent-invasive E. coli to gut environment: impact on flagellum expression and bacterial colonization ability. Gut Microbes 2018 : 1–17. [Google Scholar]
  9. Adeshirlarijaney A, Zou J, Tran HQ, et al. Amelioration of metabolic syndrome by metformin associates with reduced indices of low-grade inflammation independently of the gut microbiota. Am J Physiol Endocrinol Metab 2019 ; 317 : E1121–E1E30. [CrossRef] [PubMed] [Google Scholar]
  10. Johansson ME, Gustafsson JK, Holmén-Larsson J, et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut 2014 ; 63 : 281–291. [CrossRef] [PubMed] [Google Scholar]
  11. Lodes MJ, Cong Y, Elson CO, et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004 ; 113 : 1296–1306. [CrossRef] [PubMed] [Google Scholar]
  12. Cullender TC, Chassaing B, Janzon A, et al. Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut. Cell Host Microbe 2013 ; 14 : 571–581. [CrossRef] [PubMed] [Google Scholar]
  13. Chassaing B, Raja SM, Lewis JD, et al. Colonic microbiota encroachment correlates with dysglycemia in humans. J Clin Invest 2004 ; 113 : 1296–1306. [CrossRef] [PubMed] [Google Scholar]
  14. Tran HQ, Ley RE, Gewirtz AT, Chassaing B. Flagellin-elicited adaptive immunity suppresses flagellated microbiota and vaccinates against chronic inflammatory diseases. Nat Commun 2019 ; 10 : 1–15. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.